Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management
- Advanced Thyroid Gland Medullary Carcinoma
- Stage III Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- M.D. Anderson Cancer Center
- Enrolment target
- 2,030
- Started
- 10 January 2020
- Main results due
- 1 September 2028
- Study sites
- 2
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Aims 1 and 2: A diagnosis of MTC * Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment * Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team * Aim 3: A current registrant in the MTCR
What this study is about
In the sponsor’s own words, from the registry.
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
Study sites(2)
University of California San Francisco
San Francisco, California, United States
Recruiting
M D Anderson Cancer Center
Houston, Texas, United States
Recruiting
Showing 2 of 2 sites. 2 of the 2 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT04216732. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me